Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L8GO
|
|||
| Former ID |
DIB007366
|
|||
| Drug Name |
RK-28
|
|||
| Synonyms |
1-(4-Hydroxy-2-butenoxymethyl)-2-nitroimidazole
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Discontinued in Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H11N3O4
|
|||
| Canonical SMILES |
C1=CN(C(=N1)[N+](=O)[O-])COCC=CCO
|
|||
| InChI |
1S/C8H11N3O4/c12-5-1-2-6-15-7-10-4-3-9-8(10)11(13)14/h1-4,12H,5-7H2/b2-1+
|
|||
| InChIKey |
OGIXVTVGRBZYJM-OWOJBTEDSA-N
|
|||
| CAS Number |
CAS 93679-10-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002716) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.